| Financial Year |
March 31 2023 |
| Monetary Funds |
167,524,052.17 |
| Held-for-trading Financial Assets |
5,932,622.06 |
| Notes Receivable |
93,073,842.21 |
| Accounts Receivable |
404,501,210.66 |
| Advances to Suppliers |
12,060,280.53 |
| Other Receivables |
14,483,414.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
402,420,918.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
59,241,780.03 |
| Total Current Assets |
1,233,728,450.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
186,423.72 |
| Investment Properties |
49,611,381.46 |
| Fixed Assetes |
718,805,740.67 |
| Under-construction Projects |
118,408,564.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
177,002,176.97 |
| R&D expenses |
35,857.63 |
| Goodwill |
18,292,367.21 |
| Long-Term Deferred and Prepaid Expenses |
8,722,178.84 |
| Deferred Income Tax Assets |
53,142,780.22 |
| Other Non-Current Assets |
9,973,450.31 |
| Sub-Total of Non-Current Assets |
1,225,853,688.71 |
| Total Assets |
2,459,582,139.64 |
| Short-Term Loans |
127,313,592.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
317,983,101.73 |
| Accounts Payable |
481,853,041.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,445,170.89 |
| Taxes Payable |
27,123,009.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,424,856.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,377,596.05 |
| Other Current Liabilities |
937,969.65 |
| Sub-Total of Current Liabilities |
1,056,539,405.32 |
| Long-term Loans |
379,847,786.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
28,730,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,563,351.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
489,737,231.25 |
| Total Liabilities |
1,546,276,636.57 |
| Paid-In Capital(Or Share Stock) |
397,100,000.00 |
| Capital Surplus |
975,663,682.45 |
| Surplus Reserve |
29,613,147.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-510,525,350.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
913,305,503.07 |
| Owner's Equity（Stockholder's Equity） |
913,305,503.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,459,582,139.64 |
